2,339
Views
1
CrossRef citations to date
0
Altmetric
Metabolic Disease

Retrospective descriptive analysis of a managed care population with obesity

, , , , , , & show all
Pages 83-89 | Received 04 May 2021, Accepted 07 Oct 2021, Published online: 23 Oct 2021

References

  • Hales CM, Carroll MD, Fryar CD, et al. Prevalence of obesity and severe obesity among adults: United States, 2017–2018. NCHS Data Brief. 2020;360:1–8.
  • Xu H, Cupples LA, Stokes A, et al. Association of obesity with mortality over 24 years of weight history: findings from the framingham heart study. JAMA Netw Open. 2018;1(7):e184587.
  • Avgerinos KI, Spyrou N, Mantzoros CS, et al. Obesity and cancer risk: emerging biological mechanisms and perspectives. Metabolism. 2019;92:121–135.
  • Meurling IJ, Shea DO, Garvey JF. Obesity and sleep: a growing concern. Curr Opin Pulm Med. 2019;25(6):602–608.
  • Pereira-Miranda E, Costa PRF, Queiroz VAO, et al. Overweight and obesity associated with higher depression prevalence in adults: a systematic review and meta-analysis. J Am Coll Nutr. 2017;36(3):223–233.
  • Rajan T, Menon V. Psychiatric disorders and obesity: a review of association studies. J Postgrad Med. 2017;63(3):182–190.
  • Lauby-Secretan B, Scoccianti C, Loomis D, et al. Body fatness and cancer-viewpoint of the IARC working group. N Engl J Med. 2016;375(8):794–798.
  • Garg SK, Maurer H, Reed K, et al. Diabetes and cancer: two diseases with obesity as a common risk factor. Diabetes Obes Metab. 2014;16(2):97–110.
  • Guh DP, Zhang W, Bansback N, et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9(1):88.
  • Centers for Disease Control and Prevention. Cancer and Obesity 2017 [updated 2017 October 3; cited 2020 November 17]. Available from: https://www.cdc.gov/vitalsigns/obesity-cancer/index.html.
  • Li Q, Blume SW, Huang JC, et al. Prevalence and healthcare costs of obesity-related comorbidities: evidence from an electronic medical records system in the United States. J Med Econ. 2015;18(12):1020–1028.
  • Földi M, Farkas N, Kiss S, et al. Obesity is a risk factor for developing critical condition in COVID-19 patients: a systematic review and meta-analysis. Obes Rev. 2020;21(10):e13095–e13095.
  • Klang E, Kassim G, Soffer S, et al. Severe obesity as an independent risk factor for COVID-19 mortality in hospitalized patients younger than 50. Obesity. 2020;28(9):1595–1599.
  • Kwok S, Adam S, Ho JH, et al. Obesity: a critical risk factor in the COVID-19 pandemic. Clin Obes. 2020;10(6):e12403.
  • Lighter J, Phillips M, Hochman S, et al. Obesity in patients younger than 60 years is a risk factor for COVID-19 hospital admission. Clin Infect Dis. 2020;71(15):896–897.
  • Dietz WH, Baur LA, Hall K, et al. Management of obesity: improvement of health-care training and systems for prevention and care. Lancet. 2015;385(9986):2521–2533.
  • Soleymani T, Daniel S, Garvey WT. Weight maintenance: challenges, tools and strategies for primary care physicians. Obes Rev. 2016;17(1):81–93.
  • Khera R, Murad MH, Chandar AK, et al. Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and Meta-analysis. JAMA. 2016;315(22):2424–2434.
  • Bleich SN, Pickett-Blakely O, Cooper LA. Physician practice patterns of obesity diagnosis and weight-related counseling. Patient Educ Couns. 2011;82(1):123–129.
  • Kraschnewski JL, Sciamanna CN, Pollak KI, et al. The epidemiology of weight counseling for adults in the United States: a case of positive deviance. Int J Obes. 2013;37(5):751–753.
  • Scott and White Health Plan. About Scott and White Health Plan 2021; [cited 2021 February 26]. Available from: https://www.swhp.org/about-us.
  • U.S. Census Bureau. 2017. American Community Survey Median Household Income in the United States 2017; [cited 2021 Oct 09]. Available from: https://data.census.gov/cedsci/map.
  • Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11(1):44–47.
  • Ganguly R, Tian Y, Kong SX, et al. Persistence of newer anti-obesity medications in a real-world setting. Diabetes Res Clin Pract. 2018;143:348–356.
  • Tak YJ, Lee SY. Long-term efficacy and safety of anti-obesity treatment: where do we stand? Curr Obes Rep. 2021;10(1):14–30.
  • American Medical Association. Proceedings of the 2013 Annual Meeting of the American Medical Association House of Delegates 2013 [cited 2021 January 29]. Available from: https://www.ama-assn.org/sites/ama-assn.org/files/corp/media-browser/public/hod/a13-csaph-reports_0.pdf
  • Ciemins EL, Joshi V, Cuddeback JK, et al. Diagnosing obesity as a first step to weight loss: an observational study. Obesity. 2020;28(12):2305–2309.
  • Kyle TK, Dhurandhar EJ, Allison DB. Regarding obesity as a disease: evolving policies and their implications. Endocrinol Metab Clin North Am. 2016;45(3):511–520.